Are health insurers out of the woods after a tough 2025?
As the first-quarter earnings season wraps up, UnitedHealth Group, CVS Health, Cigna, Elevance and Centene all beat Wall Street expectations and hiked guidance. Nearly every health insurer Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR…
Last year, health insurer after health insurer slashed or withdrew their profit outlooks after being sucker-punched by high medical costs.
This year is shaping up ...
Source: Endpoints News